Login

Financial Snapshot

Revenue
TTM
$13.65B
Gross Margin
TTM
12.16%
Net Income
TTM
$309.9M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
173.68%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
1.990B
Cash
2026 Q1
P/E
TTM
38.10
Free Cash Flow
TTM
$412.1M

Stock Price

Loading...
Market Cap: $11.806 Billion

About Brightspring Health Services Inc

BrightSpring Health Services (NASDAQ: BTSG) is a home and community-based healthcare services company that delivers pharmacy, infusion, rehabilitation, hospice, and support services to patients across the care continuum. Revenue is generated through service fees and drug dispensing reimbursed primarily by Medicare, Medicaid, and commercial payors. The company carries approximately $2.6 billion in debt as of December 31, 2025, reflecting a heavily leveraged capital structure. KKR holds a significant ownership stake. Operations depend on reimbursement rates set by federal and state programs, making revenue sensitive to government budget decisions and payor mix changes. The workforce includes nurses, pharmacists, therapists, caregivers, and direct support professionals. BrightSpring conducts its operations through subsidiaries, with the parent entity, BrightSpring Health Services, Inc., serving as the registrant.

Revenue model
Fee-for-service and drug dispensing revenue reimbursed by Medicare, Medicaid, Medicare Part D, and commercial payors. Reimbursement rates are set by third-party payors and government programs rather than negotiated directly with patients.
Products and services
Home infusion therapy, outpatient rehabilitation services, hospice care, pharmacy and specialty pharmacy services, and community-based support services for individuals with neurological conditions including traumatic brain injury, spinal cord injury, and pediatric autism.
Customers and end markets
Patients receiving home and community-based care, including hospice patients, neuro-rehabilitation patients, infusion therapy patients, and individuals with developmental or neurological disabilities. Primary payors are Medicare, Medicaid, and Medicare Part D.
Value-chain role
Direct provider of home and community-based healthcare services and pharmacy dispensing, positioned between government payors and end patients.
Geographic exposure
United States. Specific state or regional revenue breakdown not disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-02-27

Industry: Services-Home Health Care Services Peers: Addus Homecare Corp Neogenomics Inc Cigna Group OPKO Health Inc LifeStance Health Group Inc Privia Health Group Inc Premier, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support